Improved Chlamydia trachomatis testing from Roche with the COBAS® TaqMan® CT Test v2.0
The COBAS® TaqMan® CT Test v2.0 is an in vitro nucleic acid amplification test for the qualitative detection of Chlamydia trachomatis DNA in female endocervical swab specimens or male and female urine, using the AMPLICOR CT/NG Sample Preparation Kit for manual specimen preparation and the COBAS® TaqMan® 48 Analyzer for automated amplification and detection.
The test has incorporated a dual-target strategy (cryptic plasmid DNA and MOMP gene genomic DNA) to ensure accurate and reliable detection of Chlamydia, including the variant strain recently found in Sweden.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.
Roche Molecular Diagnostics operates in the U.S. as the legal entity Roche Molecular Systems, Inc.
Visitor Insights Survey
Welcome to Roche Molecular Diagnostics
Whether you are a first-time visitor or a frequent visitor, we would appreciate your opinion to help improve our Web site.
Would you be willing to answer a brief questionnaire? It will take less than 5 minutes.
YesNo, thanks
This questionnaire is voluntary and your use of this Web site is not conditional upon your participation.
The questionnaire does not include any health-related questions, it strictly focuses on Web-related topics.
In accordance to Roche's privacy policy, your
responses will be treated with the strictest of confidence and not passed on to any third parties for their marketing purposes.
